Stock comparison
ImmunityBio
IBRX$7.67BHealthcare Market cap, Sector
JEENA SIKHO LIFECARE
JSLL.NS$72.75BHealthcare Market cap, Sector
Overall winner
JEENA SIKHO LIFECARE
IBRX 07 JSLL.NS
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
IBRX0wins
7winsJSLL.NS
31F
B84
45D
A87
53D
A92
52D
C66
2F
B75
53D
A91
55D
A95
Side-by-side metrics
| Metric | IBRX | JSLL.NS |
|---|---|---|
| Market cap | $7.67B | $72.75B Winner |
| P/E (TTM) | Winner: - | 33.3x |
| EV/EBIT | Winner: - | 24.1x |
| ROIC (TTM) | -44.51% | 39.15% Winner |
| Gross margin | Winner: 93.79% | 88.58% |
| Net margin | -6.06% | 27.68% Winner |
| Revenue CAGR 5y | Winner: 2.32% | 57.81% |
| EPS CAGR 5y | - | 86.67% |
| Debt / Equity | Winner: - | 0.3x |
| Dividend yield | 0.0% | - |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
IBRX leads on
- EV/EBIT-vs 24.1x+172%
- P/E (TTM)-vs 33.3x+127%
- Debt / Equity-vs 0.3x+121%
- Revenue CAGR 5y2.32%vs 57.81%+75%
JSLL.NS leads on
- ROIC (TTM)39.15%vs -44.51%+188%
- Net margin27.68%vs -6.06%+105%
- Market cap$72.75Bvs $7.67B+89%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.